<p>We talk the future of psychedelics:  decriminalization & legalization. Biotech & Pharma research, Compass Pathways (CMPS), Mind Medicine (MMED / MMEDF), Field Trip Health (FTRP) on substances like LSD, Psilocybin, Ibogaine, etc.</p>

We talk the future of psychedelics: decriminalization & legalization. Biotech & Pharma research, Compass Pathways (CMPS), Mind Medicine (MMED / MMEDF), Field Trip Health (FTRP) on substances like LSD, Psilocybin, Ibogaine, etc.

<p>We talk the future of psychedelics: &nbsp;decriminalization &amp; legalization. Biotech &amp; Pharma research, Compass Pathways (CMPS), Mind Medicine (MMED / MMEDF), Field Trip Health (FTRP) on substances like LSD, Psilocybin, Ibogaine, etc.</p>

2: the future of psychedelics

Interviews with the scientists, founders and investors driving Human 3 - the next epoch of health, wellbeing and performance. 


Topics include brain-computer interfaces, genetic medicine, psychedelics, longevity, AI and more.


Hosted by Brom Rector and Sam Tabone - founders of XEIA Venture Partners, a venture capital fund investing in Human 3. 


More at www.xeiavp.com

Technology

Interviews with the scientists, founders and investors driving Human 3 - the next epoch of health, wellbeing and performance. Topics include brain-computer interfaces, genetic medicine, psychedelics, longevity, AI and more. Hosted by Brom Rector and Sam Tabone - founders of XEIA Venture Partners, a venture capital fund investing in Human 3. More at www.xeiavp.com

Share 2: the future of psychedelics

Sign up to save your podcasts

2: the future of psychedelics

2: the future of psychedelics